THERAPEUTIC EXPERIENCE

QCTLINK Clinical’s therapeutic experience is broad – with a special focus on Regenerative Medicine and the overriding principle of program partnerships with study Sponsors.

REGENERATIVE MEDICINE

• Striatal injection
• Surgical delivery
• CNS delivery
• Read our regenerative medicine clinical trial trends report.

OPHTHALMOLOGY

• Congenital Retinal Disease
• Macular Disease
  • Rare and/or Genetic indications
  • Pediatric and adults
  • Subretinal injection
  • Intravitreal injection
  • Adaptive optics retinal imaging
  • Age-related Macular Degeneration
• Stem Cell
• Gene Therapy
• Read our ophthalmology clinical trial trends report.

CNS/PAIN

• Chronic Pain
• CNS Drug Delivery/Device
• Neuropathic Pain
• Surgical/Acute Pain

PULMONARY

• COPD
• Pulmonary Arterial Hypertension (PAH)
• Pulmonary Fibrosis
• Lung Penetration

NUTRITION

• Dietary supplements
• Food ingredients

ANTI INFECTIVES

• Antibiotics Therapy
• Hepatitis
• HIV/AIDS
• Vaccine Therapy

NEUROLOGY

• Amyotrophic Lateral Sclerosis (ALS)
• Cognitive Impairment
• MPS (Pediatric)
• Myasthenia Gravis (MG)
• Parkinson’s Disease
• Sleep Studies
• Read our neurology clinical trial trends report.

ONCOLOGY

• Non-Hodgkin’s Lymphoma
• Solid Tumors
• Glioblastoma
• Brain/Breast/Bladder/Colon/Lung Cancer
• Head and Neck Cancer
• AML
• NHL
• Myeloma
• Hematology

ENDOCRINOLOGY

• Adrenal Disease
• Diabetes

GASTROENTEROLOGY

• Celiac Disease
• Gastroparesis

CARDIOVASCULAR

• Hypertension
• Nuclear Imaging
• Stents
• Valve Replacement

AUTOIMMUNE DISORDERS

• Celiac Disease
• Lupis
• Myasthenia Gravis
• MS

We have experience in conducting and supporting early-phase healthy subjects Phase I studies, Phase II, III, Registries, regenerative (stem cell), rare/orphan drug trials, as well as various medical devices and diagnostics studies:

DRUGS

• Phase I-IV
• Registries
• Rare/Orphan drugs
• Regenerative (Stem Cell)
• Biosimilars

MEDICAL DEVICES & DIAGNOSTICS

• Non-inferiority
• PMA
• Pilot studies
• CED